241 related articles for article (PubMed ID: 9173018)
1. [Is the anxiety about Ecstasy justified?].
Möller-Nehring E; Luderer HJ
Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
3. [Psychiatric and cognitive long-term effects of ecstasy].
Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
[TBL] [Abstract][Full Text] [Related]
4. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
[TBL] [Abstract][Full Text] [Related]
5. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
Molero-Chamizo A
Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
[TBL] [Abstract][Full Text] [Related]
6. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
7. Ecstasy (MDMA) and oral health.
Brand HS; Dun SN; Nieuw Amerongen AV
Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
[TBL] [Abstract][Full Text] [Related]
8. 3,4-methylenedioxymethamphetamine (MDMA): a review.
O'Leary G; Nargiso J; Weiss RD
Curr Psychiatry Rep; 2001 Dec; 3(6):477-83. PubMed ID: 11707161
[TBL] [Abstract][Full Text] [Related]
9. Ecstasy: pharmacology and neurotoxicity.
Morton J
Curr Opin Pharmacol; 2005 Feb; 5(1):79-86. PubMed ID: 15661630
[TBL] [Abstract][Full Text] [Related]
10. [Neurotoxicity of the drug Ecstasy. Functional consequences of serotonergic hypoactivity].
de Visme PG
Ugeskr Laeger; 1998 Oct; 160(42):6088-91. PubMed ID: 9800515
[TBL] [Abstract][Full Text] [Related]
11. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
Casco C; Forcella M; Beretta G; Grieco A; Campana G
Addict Biol; 2005 Jun; 10(2):187-95. PubMed ID: 16191672
[TBL] [Abstract][Full Text] [Related]
13. MDMA and serotonin: based on two cases.
Garcia Cabeza I; Zabala A; Soto-Montenegro ML; Arango C
Actas Esp Psiquiatr; 2005; 33(5):339-42. PubMed ID: 16155817
[TBL] [Abstract][Full Text] [Related]
14. [Effects of ecstasy on the body].
Saarijärvi S; Lopperi M
Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
[No Abstract] [Full Text] [Related]
15. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
16. [Ecstasy].
Ege PP
Ugeskr Laeger; 2000 Jul; 162(31):4161-2. PubMed ID: 10962923
[No Abstract] [Full Text] [Related]
17. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Karlsen SN; Spigset O; Slørdal L
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
[TBL] [Abstract][Full Text] [Related]
18. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
McCoy EP; Renfrew C; Johnston JR; Lavery G
Ulster Med J; 1994 Apr; 63(1):103-7. PubMed ID: 8658983
[No Abstract] [Full Text] [Related]
20. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
